Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

May 13, 2013 – New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of ...

Home May 15, 2013
Home
Feature

May 14, 2013 — nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from ...

Home May 14, 2013
Home
News

May 14, 2013 — Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool ...

Home May 14, 2013
Home
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature

May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrat ...

Home May 13, 2013
Home
News

May 13, 2013 — Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study ...

Home May 13, 2013
Home
Technology

April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human) ...

Home April 30, 2013
Home
Technology

April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner ...

Home April 05, 2013
Home
News

April 4, 2013 — Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the ...

Home April 04, 2013
Home
News

April 4, 2013 — iRhythm Technologies Inc. announced clinical study findings showing that use of the Zio Patch resulted ...

Home April 04, 2013
Home
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature

March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co ...

Home March 19, 2013
Home
Feature

March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company ...

Home March 13, 2013
Home
Technology

February 25, 2013 — The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX ...

Home February 25, 2013
Home
Top stories of 2012 in cardiology
Feature | Dave Fornell

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on ...

Home January 29, 2013
Home
News

January 21, 2013 — The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to ...

Home January 21, 2013
Home
News

January 21, 2013 — At the Boston Atrial Fibrillation (AF) Symposium 2013, Philips Healthcare introduced its latest ...

Home January 21, 2013
Home
Subscribe Now